Education
About Us
Working with TipRanks
Follow Us
AngioDynamics (ANGO)
NASDAQ:ANGO
Earnings Data
Report Date
Jan 01, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.04Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth across various segments, particularly in the Med Tech and Mechanical Thrombectomy areas, and a positive outlook with increased guidance. However, tariff expenses and a continued adjusted net loss were concerns.Company Guidance
Significant Revenue Growth
Overall revenue grew by 12.2% to $75.7 million, with the Med Tech segment growing 26.1% and Medical Device segment growing 2.3%.
Med Tech Segment Success
The Med Tech segment now comprises 47% of total revenue, up from 41% a year ago, with a compound annual growth rate of 25% over the past 5 years.
Auryon Platform Performance
Auryon delivered $16.5 million in revenue, growing 20.1% compared to last year and achieving 17 consecutive quarters of double-digit year-over-year growth.
Mechanical Thrombectomy Growth
Mechanical Thrombectomy revenue increased 41.2% year-over-year, with AngioVac and AlphaVac contributing significantly.
NanoKnife Expansion
NanoKnife revenue grew by 26.7%, driven by expanded prostate indications and anticipated CPT I code effectiveness in January.
Increased Guidance for Fiscal 2026
Net sales guidance was raised to $308 million to $313 million. Med Tech net sales are expected to grow 14% to 16%.
ANGO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ANGO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 02, 2025 | $11.07 | $11.74 | +6.05% |
Jul 15, 2025 | $9.63 | $8.65 | -10.18% |
Apr 02, 2025 | $9.66 | $10.86 | +12.42% |
Jan 08, 2025 | $9.40 | $12.94 | +37.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AngioDynamics (ANGO) report earnings?
AngioDynamics (ANGO) is schdueled to report earning on Jan 01, 2026, Before Open (Confirmed).
What is AngioDynamics (ANGO) earnings time?
AngioDynamics (ANGO) earnings time is at Jan 01, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ANGO EPS forecast?
ANGO EPS forecast for the fiscal quarter 2026 (Q2) is -0.1.
